NASDAQ Companies

Launched VOQUEZNA® (vonoprazan) tablets in November 2023 for the treatment of Erosive GERD (gastroesophageal reflux disease), achieving net revenues of […]

SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on […]

SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business […]

NEW HOPE, Pa., March 07, 2024 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), […]

GREENWICH, Conn., March 07, 2024 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) […]

Data support evaluation of the effects of two weeks of TNX-102 SL therapy on severity of acute stress reaction (ASR) […]

SCOTTSDALE, Ariz., March 07, 2024 (GLOBE NEWSWIRE) — Adamas One Corp. (NASDAQ: JEWL), a leading innovator in lab-grown diamond technology, […]

DALLAS, March 07, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence […]

HORSHAM, Pa., March 07, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology […]

The Company’s most recent patent further solidifies its position, complementing existing grants in the U.S., Japan, Australia and other key […]